欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1308/001
药品名称Levofloxacine Kabi 5 mg/ml , solution for infusion
活性成分
    • levofloxacin hemihydrate 5.0 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Nederland BV 's Hertogenbosch Nederland
参考成员国 - 产品名称Netherlands (NL)
Levofloxacine Fresenius Kabi 5mg/ml, oplossing voor infusie
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Poland (PL)
      Levofloxacin Kabi
    • Czechia (CZ)
      Levofloxacin Kabi 5mg/ml infuzní roztok
    • Slovakia (SK)
    • Germany (DE)
    • Belgium (BE)
    • Ireland (IE)
    • Austria (AT)
      Levofloxacin Kabi 5 mg/ml Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Finland (FI)
    • Hungary (HU)
      LEVOFLOXACIN KABI 5 mg/ml oldatos infúzió
    • Bulgaria (BG)
      Levofloxacin Kabi
    • Cyprus (CY)
    • Romania (RO)
      Levofloxacin Kabi 5 mg/ml soluţie perfuzabilă
    • Slovenia (SI)
    • Malta (MT)
许可日期2009/01/30
最近更新日期2024/10/17
药物ATC编码
    • J01MA12 levofloxacin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase